106 related articles for article (PubMed ID: 37621085)
1. Factors associated with household transmission of SARS-CoV-2 omicron variant to health care workers: A retrospective cohort study.
Kagami K; Oyamada R; Watanabe T; Nakakubo S; Hayashi T; Iwasaki S; Fukumoto T; Usami T; Hayasaka K; Fujisawa S; Watanabe C; Nishida M; Teshima T; Niinuma Y; Yokota I; Takekuma Y; Sugawara M; Ishiguro N
Int J Nurs Pract; 2023 Oct; 29(5):e13195. PubMed ID: 37621085
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
Cegolon L; Magnano G; Negro C; Larese Filon F;
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
[No Abstract] [Full Text] [Related]
3. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
Cegolon L; Negro C; Mastrangelo G; Filon FL;
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
[No Abstract] [Full Text] [Related]
4. Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.
Saade C; Brengel-Pesce K; Gaymard A; Trabaud MA; Destras G; Oriol G; Cheynet V; Debombourg M; Mokdad B; Billaud G; Oblette A; Créhalet H; Giannoli JM; Garrigou C; Generenaz L; Compagnon C; Boibieux A; Lina B; Morfin F; Pozzetto B; Josset L; Trouillet-Assant S; Bal A
Emerg Microbes Infect; 2022 Dec; 11(1):2423-2432. PubMed ID: 36098494
[TBL] [Abstract][Full Text] [Related]
5. Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants.
Kim YC; Kim B; Son NH; Heo N; Nam Y; Shin A; Yang AJ; Kim MH; Kyong T; Kang E; Park YS; Kim H
J Korean Med Sci; 2023 Jan; 38(1):e9. PubMed ID: 36593690
[TBL] [Abstract][Full Text] [Related]
6. Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms.
Keske Ş; Güney-Esken G; Vatansever C; Beşli Y; Kuloğlu ZE; Nergiz Z; Barlas T; Şencanlı Ö; Kuşkucu MA; Palaoğlu E; Can F; Önder Ergönül
Clin Microbiol Infect; 2023 Feb; 29(2):221-224. PubMed ID: 35853589
[TBL] [Abstract][Full Text] [Related]
7. Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea.
Lee J; Ko M; Kim S; Lim D; Park G; Lee SE
Osong Public Health Res Perspect; 2023 Aug; 14(4):263-271. PubMed ID: 37652681
[TBL] [Abstract][Full Text] [Related]
8. Risk of transmission of COVID-19 from healthcare workers returning to work after a 5-day isolation, and kinetics of shedding of viable SARS-CoV-2 variant B.1.1.529 (Omicron).
Jung J; Kang SW; Lee S; Park H; Kim JY; Kim SK; Park S; Lim YJ; Kim EO; Lim SY; Chang E; Bae S; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Park MS; Kim SH
J Hosp Infect; 2023 Jan; 131():228-233. PubMed ID: 36460176
[TBL] [Abstract][Full Text] [Related]
9. Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.
Lin Y; Wu P; Tsang TK; Wong JY; Lau EHY; Yang B; Leung GM; Cowling BJ
Lancet Microbe; 2023 Sep; 4(9):e722-e731. PubMed ID: 37659420
[TBL] [Abstract][Full Text] [Related]
10. Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) between hospital workers and members of their household: Nationwide, registry-based, cohort study from Norway.
Elgersma IH; Telle K; Elstrøm P; Skagseth H; Kacelnik O
Infect Control Hosp Epidemiol; 2023 Apr; 44(4):604-609. PubMed ID: 35485709
[TBL] [Abstract][Full Text] [Related]
11. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
12. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
13. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit JD; Gómez-Olivé FX; Dawood FS; Mkhencele T; Sun K; Viboud C; Tempia S;
Lancet Infect Dis; 2022 Jun; 22(6):821-834. PubMed ID: 35298900
[TBL] [Abstract][Full Text] [Related]
15. Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
; Thompson MG; Yoon SK; Naleway AL; Meece J; Fabrizio TP; Caban-Martinez AJ; Burgess JL; Gaglani M; Olsho LEW; Bateman A; Lundgren J; Grant L; Phillips AL; Groom HC; Stefanski E; Solle NS; Ellingson K; Lutrick K; Dunnigan K; Wesley MG; Guenther K; Hunt A; Mak J; Hegmann KT; Kuntz JL; Bissonnette A; Hollister J; Rose S; Morrill TC; Respet K; Fowlkes AL; Thiese MS; Rivers P; Herring MK; Odean MJ; Yoo YM; Brunner M; Bedrick EJ; Fleary DE; Jones JT; Praggastis J; Romine J; Dickerson M; Khan SM; Lamberte JM; Beitel S; Webby RJ; Tyner HL
JAMA; 2022 Oct; 328(15):1523-1533. PubMed ID: 36255426
[TBL] [Abstract][Full Text] [Related]
16. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
[TBL] [Abstract][Full Text] [Related]
17. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong.
Zee ST; Kwok LF; Kee KM; Fung LH; Luk WP; Chan TL; Leung CP; Yu PW; Hung J; SzeTo KY; Chan WL; Tang SF; Lin WC; Ma SK; Lee KH; Lau CC; Yung WH
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016210
[TBL] [Abstract][Full Text] [Related]
18. Effects of vaccines on clinical characteristics of convalescent adult patients infected with SARS-CoV-2 Omicron variant: A retrospective study.
Wang J; Dong H; Zhao J; Li T; Wang M; Zhou C; Mu H
Front Microbiol; 2023; 14():1096022. PubMed ID: 37065120
[TBL] [Abstract][Full Text] [Related]
19. Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study.
Wei Z; Ma W; Wang Z; Li J; Fu X; Chang H; Qiu Y; Tian H; Zhu Y; Xia A; Wu Q; Liu G; Zhai X; Zhang X; Wang Y; Zeng M
Influenza Other Respir Viruses; 2023 Feb; 17(2):e13097. PubMed ID: 36843225
[TBL] [Abstract][Full Text] [Related]
20. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
